These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [The modern approach to the treatment for onychomycosis of hands and feet in the outpatient setting]. Gerasimchuk EV; Gerasimov VV; Molchanov BA Voen Med Zh; 2005 Nov; 326(11):44-5. PubMed ID: 16404907 [No Abstract] [Full Text] [Related]
4. [Terbinafine-induced persistent agueusia: first reported case]. Schmutz JL; Barbaud A; Tréchot P Ann Dermatol Venereol; 2000 Mar; 127(3):341. PubMed ID: 10804319 [No Abstract] [Full Text] [Related]
5. A pilot evaluation of pulse itraconazole vs. terbinafine for treatment of Candida toenail onychomycosis. Warshaw EM; Nelson D; Carver SM; Zielke GR; Webster N; Lederle FA; Fett DD Int J Dermatol; 2005 Sep; 44(9):785-8. PubMed ID: 16135154 [No Abstract] [Full Text] [Related]
7. Efficacy of amorolfine nail lacquer for the prophylaxis of onychomycosis over 3 years. Sigurgeirsson B; Olafsson JH; Steinsson JT; Kerrouche N; Sidou F J Eur Acad Dermatol Venereol; 2010 Aug; 24(8):910-5. PubMed ID: 20028447 [TBL] [Abstract][Full Text] [Related]
8. Terbinafine and onychomycosis. Eastcott DF N Z Med J; 1991 Jan; 104(904):17. PubMed ID: 1826145 [No Abstract] [Full Text] [Related]
9. [Glossopyrosis and terbinafine]. Haneke E Dtsch Med Wochenschr; 1999 Oct; 124(40):1186. PubMed ID: 10548951 [No Abstract] [Full Text] [Related]
10. Open-label study of the efficacy and safety of topical treatment with TDT 067 (terbinafine in Transfersome®) in patients with onychomycosis. Dominicus R; Weidner C; Tate H; Kroon HA Br J Dermatol; 2012 Jun; 166(6):1360-2. PubMed ID: 22136723 [No Abstract] [Full Text] [Related]
11. Reversible agranulocytosis associated with oral terbinafine for onychomycosis. Ornstein DL; Ely P J Am Acad Dermatol; 1998 Dec; 39(6):1023-4. PubMed ID: 9843023 [No Abstract] [Full Text] [Related]
12. [Diagnosis and treatment of onychomycoses with terbinafine (Lamisil)]. Baudraz F; Rakosi T Rev Med Suisse Romande; 1998 Nov; 118(11):975-9. PubMed ID: 9865129 [No Abstract] [Full Text] [Related]
13. Curing onychomycosis: understanding the multitude of variables. Lagana FJ Clin Podiatr Med Surg; 2004 Oct; 21(4):555-64, vi. PubMed ID: 15450896 [TBL] [Abstract][Full Text] [Related]
14. Oral treatment of onychomycosis. Ellis MR; Kane KY J Fam Pract; 1999 Apr; 48(4):252. PubMed ID: 10229245 [No Abstract] [Full Text] [Related]
15. Terbinafine for onychomycosis. Med Lett Drugs Ther; 1996 Aug; 38(981):72-4. PubMed ID: 8699988 [No Abstract] [Full Text] [Related]
17. Large-scale epidemiological study of the causal agents of onychomycosis: mycological findings from the Multicenter Onychomycosis Study of Terbinafine. Elewski BE Arch Dermatol; 1997 Oct; 133(10):1317-8. PubMed ID: 9382581 [No Abstract] [Full Text] [Related]